Rheumatoid arthritis: Treatment which controls the c-reactive protein and erythrocyte sedimentation rate reduces radiological progression

Rheumatology

Volumn 25, Issue 1, 1986, Pages 44-49

  Dawes, P T ^a   Fowler, P D ^a   Clarke, S ^a   Fisher, J ^a   Lawton, A ^a   Shadforth, M F ^a  

^a HAYWOOD HOSPITAL   (United Kingdom)

Author keywords

CRP; ESR; Radiological progression; Rheumatoid arthritis; Suppressive therapy

Indexed keywords

C REACTIVE PROTEIN; CHLOROQUINE; DAPSONE; GOLD; PENICILLAMINE;

ADULT; BLOOD AND HEMOPOIETIC SYSTEM; BONE; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; JOINT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOLOGY; RHEUMATOID ARTHRITIS; THERAPY;

ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CHLOROQUINE; DAPSONE; DRUG EVALUATION; GOLD; HUMANS; PENICILLAMINE; RHEUMATOID FACTOR;

EID: 0022627532     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/25.1.44     Document Type: Article

References (18)

1. Wright V. Amos R. Do drugs change the course of rheumatoid arthritis. Br Med J 1980; 280:964–6.
2. Editorial. Inducing remission in rheumatoid arthritis. Lancet 1981;i:193–4.
3. McConkey B. Crockson RA. Crockson AP. Wiliamson AR. The effects of some anti-inflammatory drugs on the acute phase proteins in rheumatoid arthritis. Q J Med 1973;42:785–91.
4. Constable TJ. Crockson R A. Crockson AP. McConkey B. Drug treatment of rheumatoid arthritis. Lancet 1975:1176–9.
5. Fowler PD, Shadforth MF, Crook PR, Lawton A. Report on chloroquine and dapsone in the treatment of rheumatoid arthritis: a 6 month comparative study. Ann Rheum Dis 1984;43:200–4.
6. Amos RS, Crockson RA, Crockson AP, Walsh L, McConkey B. Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial therapy. Br Med J 1978;1:1396.
7. Amos RS, Constable TJ, Crockson RA, Crockson AP, McConkey B. Rheumatoid arthritis: a relation of serum C-reactive protein and erythrocyte sedimentaion rates to radiographic changes. Br Med J 1977;1:195–7.
8. Scott DL, Grindulis KA, Struthers GR, Coulton BL, Popert AJ, Bacon PA. Progress of radiological changes in rheumatoid arthritis. Ann Rheum Dis 1984;43:8–17.
9. Iannuzzi L, Dawson N, Zein N, Kushner I. Does any therapy slow radiographic deterioration in rheumatoid arthritis. N Engl J Med 1983;309:1023–7.
10. Kirwan JR, Currey HLF. Rheumatoid arthritis—disease modifying anti-rheumatic drugs. Clin Rheum Dis 1983;9:581–600.
11. Research subcommittee of the Empire Rheumatism Council. Gold therapy in rheumatoid arthritis: report of a multicentre controlled trial. Ann Rheum Dis 1960;19:95–117.
12. Co-operating clinics: committee of the American Rheumatism Association. A controlled trial of gold salt therapy in rheumatoid arthritis. Arthritis Rheum 1973;16:353–8.
13. Multicentre Trial Group. Controlled trial of D-Penicillamine in severe rheumatoid arthritis. Lancet 1973;1:275–80.
14. Sigler JW, Bluhm GB, Duncan H, Sharp JT, Ensign DC, McCrann WR. Gold salts in the treatment of rheumatoid arthritis. A double blind study. Ann Intern Med 1974;80:21–6.
15. Larsen A, Dale K, Eck M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol (diagn Stockh) 1977;18:481–91.
16. Pullar T, Hunter JA, Capell HA. Does second-line therapy affect the radiological progression of rheumatoid arthritis. Ann Rheum Dis 1984;43:18–23.
17. Ahern MJ, Hall ND, Case K, Maddison PJ. D-Penicillamine withdrawal in rheumatoid arthritis. Ann Rheum Dis 1984;43:213–7.
18. Pullar T, Capell HA. A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question? Ann Rheum Dis 1985;44:134–40.